Law
Amgen’s cholesterol drug patent revoked in UPC first
A European patent for a drug used in the treatment of high cholesterol has become the first to be revoked following full trial proceedings before the Unified Patent Court (UPC).
Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!
Easy Branches
34/17 Moo 3 Chao fah west Road, Phuket, Thailand, PhuketCall: 076 367 766
info@easybranches.comA European patent for a drug used in the treatment of high cholesterol has become the first to be revoked following full trial proceedings before the Unified Patent Court (UPC).